On Monday shares of IAC/InterActiveCorp (NASDAQ:IACI) closed at $72.55. Company’s sales growth for last 5 years was 18.20% and EPS growth for next 5 years is recorded as 13.33%. On April 9, Multimedia entertainment studio Electus, an operating business of IAC (NASDAQ:IACI), announced the programming slate Electus International will be bringing to market at MIPTV 2015 in Cannes, France. The studio’s offerings reflect a mix of scripted, unscripted, and event programming, and include original series concepts developed by Electus and its partners, as well as successful third party series that Electus has acquired for international distribution. Electus International will be located at stand R8:B18.
Altera Corp. (NASDAQ:ALTR) in last trading activity fell -1.48% to close at $43.86. Company weekly performance is 6.43% while its quarterly performance stands at 19.31%. Altera Corp. (NASDAQ:ALTR) is -3.35% away from its 52 week high. Several shareholders of chipmaker Altera Corp. (NASDAQ:ALTR), including Cadian Capital Management and TIG Advisors, have urged the company to resume takeover talks with Intel Corp, Bloomberg reported, citing people familiar with the matter.
On last trading day LightPath Technologies, Inc. (NASDAQ:LPTH) fell -4.67% to close at $1.02. Its volatility for the week is 6.19% while volatility for the month is 4.35%. LPTH’s sales growth for past 5 years was 9.50% and its EPS growth for past 5 years was 49.70%. LightPath Technologies, Inc. (NASDAQ:LPTH) monthly performance is 2.00%. LightPath Technologies, Inc. (NASDAQ:LPTH) announced it will exhibit at SPIE Defense, Security + Sensing 2015. The show takes place April 21st through April 23rd at the Baltimore Convention Center in Baltimore, MD.
MiMedx Group, Inc. (NASDAQ:MDXG) has 5.40% insider ownership while its institutional ownership stands at 40.80%. In last trading activity company’s stock closed at $10.85. MiMedx Group, Inc. (NASDAQ:MDXG), announced the updated status of the Company’s payer coverage from commercial health plans and state Medicaid programs. 53 million covered lives added from 27 new plans during the quarter; and 10 Blue Cross/Blue Shield plans encompassing 20 states added during the quarter.
On last trading day Syneron Medical Ltd. (NASDAQ:ELOS) advanced 0.16% to close at $12.56. Its volatility for the week is 1.78% while volatility for the month is 3.01%. ELOS’s sales growth for past 5 years was 36.10% and its EPS growth for past 5 years was 30.40%. Syneron Medical Ltd. (NASDAQ:ELOS) monthly performance is 5.46%. Brean Capital set a $18.00 price objective on Syneron Medical (NASDAQ:ELOS) in a research report released on Monday morning. The firm currently has a a buy rating on the stock.